Skip to main content
Full access
Clinical And Research Reports
Published Online: 1 April 2013

The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

The authors studied the efficacy and safety of combined venlafaxine and quetiapine treatment for treatment-resistant depression (TRD) by dividing 95 TRD patients into two treatment groups: a combined venlafaxine (225 mg/day) and quetiapine (400 mg/day) group and a venlafaxine-only (225 mg/day) group for 8 weeks. Efficacy was assessed with the Hamilton Rating Scale for Depression, 17 items (Ham-D–17) and the Hamilton Rating Scale for Anxiety (Ham-A); safety was assessed with the Treatment-Emergent Symptom Scale (TESS). The two groups showed significant differences for the Ham-D–17 and Ham-A and no differences on the TESS. Combined venlafaxine and quetiapine treatment showed good efficacy and safety in TRD.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 157 - 160
PubMed: 23686035

History

Received: 12 July 2012
Accepted: 1 October 2012
Published online: 1 April 2013
Published in print: Spring 2013

Authors

Affiliations

Xiaoyi Li, M.D.
From the Dept. of Psychiatry and Mental Health, Tongde Hospital of Zhejiang Province, Hangzhou, China; The Mental Health Institute of Zhejiang Province, Hangzhou, China; Dept., of Psychiatry and Mental Health, The People’s Hospital of Zhejiang Province, Hangzhou, China; Dept. of Psychiatry and Mental Health, SIR RUN RUN SHAW Hospital, Zhejiang University School of Medicine, Hangzhou, China; SIR RUN RUN SHAW Institute of Clinical Medicine of Zhejiang University, Hangzhou, China.
Baoping Xing, Bachelor of Medicine
From the Dept. of Psychiatry and Mental Health, Tongde Hospital of Zhejiang Province, Hangzhou, China; The Mental Health Institute of Zhejiang Province, Hangzhou, China; Dept., of Psychiatry and Mental Health, The People’s Hospital of Zhejiang Province, Hangzhou, China; Dept. of Psychiatry and Mental Health, SIR RUN RUN SHAW Hospital, Zhejiang University School of Medicine, Hangzhou, China; SIR RUN RUN SHAW Institute of Clinical Medicine of Zhejiang University, Hangzhou, China.
Enyan Yu, M.D.
From the Dept. of Psychiatry and Mental Health, Tongde Hospital of Zhejiang Province, Hangzhou, China; The Mental Health Institute of Zhejiang Province, Hangzhou, China; Dept., of Psychiatry and Mental Health, The People’s Hospital of Zhejiang Province, Hangzhou, China; Dept. of Psychiatry and Mental Health, SIR RUN RUN SHAW Hospital, Zhejiang University School of Medicine, Hangzhou, China; SIR RUN RUN SHAW Institute of Clinical Medicine of Zhejiang University, Hangzhou, China.
Wei Chen, Bachelor of Medicine
From the Dept. of Psychiatry and Mental Health, Tongde Hospital of Zhejiang Province, Hangzhou, China; The Mental Health Institute of Zhejiang Province, Hangzhou, China; Dept., of Psychiatry and Mental Health, The People’s Hospital of Zhejiang Province, Hangzhou, China; Dept. of Psychiatry and Mental Health, SIR RUN RUN SHAW Hospital, Zhejiang University School of Medicine, Hangzhou, China; SIR RUN RUN SHAW Institute of Clinical Medicine of Zhejiang University, Hangzhou, China.
Hao Wu, M.D.
From the Dept. of Psychiatry and Mental Health, Tongde Hospital of Zhejiang Province, Hangzhou, China; The Mental Health Institute of Zhejiang Province, Hangzhou, China; Dept., of Psychiatry and Mental Health, The People’s Hospital of Zhejiang Province, Hangzhou, China; Dept. of Psychiatry and Mental Health, SIR RUN RUN SHAW Hospital, Zhejiang University School of Medicine, Hangzhou, China; SIR RUN RUN SHAW Institute of Clinical Medicine of Zhejiang University, Hangzhou, China.

Notes

Send correspondence to Dr. Hao Wu, Dept. of Psychiatry and Mental Health, SIR RUN RUN SHAW Hospital, Zhejiang University School of Medicine, Hangzhou, China; e-mail: [email protected]

Funding Information

All authors declare no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share